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Copyright © 2007 AHC To assess the effect of milk on the development of 7,12-dimethylbenz(a)anthracene
(DMBA)-induced mammary tumors, 48 female Sprague-Dawley rats treated with DMBA
were divided into 3 groups and given 1 of 3 test solutions for 20 weeks as their drinking
liquid: milk, estrone sulfate solution or tap water. The milk group showed a significantly great
incidence (75%) in tumor development compared with the water group (38%) and was com-
parable to the estrone sulfate group (69%). Mean tumor number per rat in the milk group
was significantly higher than that in the water group (p=0.009). We classified the mammary
tumors into three histological types: intraductal papilloma, fibroadenoma, and adenocarci-
noma. Although the percent of intraductal papilloma and fibroadenoma was almost same
among the three groups, malignant tumor was found only in the milk and estrone sulfate
groups. In conclusion, our results indicate that milk as well as estrone sulfate promotes
the development of DMBA-induced mammary tumors in rat and could be associated with
the occurrence of adenocarcinoma.
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I. Introduction
Breast cancer is the most common malignant neoplasm,
and is the number one cause of cancer-related deaths in
nonsmoking women [3]. The incidence of breast cancer has
been increasing in both developed and developing countries
[4]. Although epidemiological studies have identified vari-
ous risk factors, including obesity, menarche at young age,
and late menopause, these known risk factors seem to ac-
count for only a third of the breast cancer cases [10, 23].
Recently, an epidemiological analysis revealed that the in-
cidence of breast cancer in 42 countries is highly correlated
(r=0.79) with the consumption of milk and dairy products
[22]. The positive association between milk and breast can-
cer has been proved by some case-control studies and cohort
studies [18, 26].
Recently, Qin et al. reported that low-fat milk pro-
moted the development of 7,12-dimethylbenz(a)anthracene
(DMBA)-induced mammary tumors in rats [17]. But they
did not thoroughly observe their natural history and mor-
phology, or perform pathological classification for experi-
mental tumors to assess the effects of milk on morphology
and pathology of tumors. It is possible to evaluate tumori-
genic response by palpable tumors, but the true nature of
palpable  lesions  can be determined only through histo-
logical examination [21]. Moreover, the classification of
tumors is very useful for the further interpretation of ex-
perimental data [21]. In the present study, we performed
haematoxylin-eosin staining (HE) and carefully implement-
ed pathological classification for all experimental tumors.
Since the presence of myoepithelial cells is commonly
regarded as the hallmark of benignity for human tumors [2,
14] and proliferating cell nuclear antigen (PCNA) is sensi-Ma et al. 62
tive enough to differentiate between benign tumors and
malignant tumors [20], we also performed smooth muscle
actin (SMA) and PCNA immunohistochemistry staining to
identify the differences among different histological types
of rat mammary tumors. In addition, all tumors were eval-
uated for estrogen receptor α (ERα) by immunohistochem-
istry.
II. Material and Methods
Animal experimental procedure and care of laboratory
animals followed the Guidelines for Animal Experiments of
Peking University. After one week of acclimation to com-
mercial powder chow and water, all of the 48 6-week old
female Sprague-Dawley (SD) rats (Beijing Vital River
Laboratory Animal Company, Beijing, China) received one
intragastric intubation of 5 mg DMBA (Sigma-Aldrich, St.
Louis, MO) dissolved in 0.5 ml corn oil. Twenty-four hours
after DMBA administration, rats were assigned at random
into 3 groups of 16 animals each and given 1 of 3 test
solutions: milk, estrone sulfate solution or tap water for
20 weeks. The milk was purchased everyday at local super-
market. Estrone sulfate (Sigma-Aldrich) was dissolved in
tap water at a concentration of 100 ng/ml.
Food intake and body weight were recorded weekly.
Rats were palpated weekly to monitor tumor development.
During the 20th week after DMBA administration, complete
autopsies were performed. All organs were examined for
gross abnormalities. Visible mammary tumors were rapidly
excised and weighed. To carry out histological examination,
the tumor with the adjacent normal gland was fixed in 10%
neutral buffered formalin and embedded in paraffin. Tissue
sections were cut at 2 µm and stained with HE.
For immunohistochemistry analysis, the following
antibodies were used: mouse anti-alpha SMA monoclonal
antibody (DAKO Corp., Carpinteria, CA, USA), mouse
anti-PCNA antibody (clone, PC10; DAKO Corp.), or mouse
anti-human ERα antibody (clone, ID5; DAKO Corp.). Anti-
mouse and anti-rabbit, labeled polymer, horseradish peroxi-
dase (DAKO Corp.) were applied to the sections as a second
antibody.
For ERα staining, paraffin sections were cut one day
prior to immunohistochemistry staining because the immu-
noreactivity of ERα in paraffin sections can diminish over
time [9]. Procedures of immunohistochemistry staining for
SMA, PCNA, and ERα have been described elsewhere [9,
12, 15]. Briefly, after removing paraffin wax in three
changes of xylene and dehydration in a series of graded
ethanol, sections were autoclaved at 121°C for 10 min in
citrate buffer (pH 6.0) for antigen retrieval. Endogenous
peroxidase was blocked by immersing the sections in 3%
H2O2 for 10 min. Sections were incubated for 1 hr at room
temperature with the primary antibody. Tissue sections were
then reacted with the conjugated second-antibody, horse-
radish peroxidase, for 40 min at room temperature. Visual-
ization of SMA, PCNA, and ERα was performed with
diaminobenzidine for 3 min. After counterstaining with
haematoxylin  for  10 s, sections  were  dehydrated  in  a
series of graded ethanol, cleared in 3 changes of xylene and
coverslipped for light microscopic examination.
We performed histological diagnosis according to the
classification described by Russo and Russo [21].
Statistical analysis
Fisher’s exact probability test was used to compare the
percentage of animals with tumors and tumor histology type
in each group. Mean number of tumors per rat and PCNA
labeling index among the three histological types were
analyzed by one-way ANOVA followed by LSD multiple
comparison tests. Statistical significance was set at p<0.05.
Data analyses were performed using SPSS version 11.0 for
Windows (SPSS Inc., Tokyo, Japan).
III. Results
Prevalence of mammary tumors
During the period of observation, 48 rats developed
103 mammary tumors. Multiple tumors of different sizes
were frequently found in the same rat. Results of mammary
tumor development are shown in Table 1. The first tumors
were detected at week 6 after DMBA administration in the
milk and estrone sulfate groups. Palpable tumors in the
water group did not appear until week 9 after DMBA ad-
ministration. At week 20 after DMBA administration,
tumor incidence was 75% (12/16) in milk group, 69%
(11/16) in estrone sulfate group, and 38% (6/16) in water
group. Milk group showed a significantly greater incidence
in tumor development compared with the water group
(p=0.037). Tumor incidence of estrone sulfate group was
also high but not significantly different from that of the
water group. Tumor incidence of milk group is comparable
to that of estrone sulfate group. More than one third as
many tumors were seen in the milk group as in the water
group, and rats in the estrone sulfate group developed al-
most twice as many tumors as did rats in the water group. No
significant difference in number was observed between the
Table 1. Prevalence of DMBA-induced mammary tumors in three groups
I, milk group; II, estrone sulfate group; III, water group; SE, standard error.
Group No. of rats Tumor incidence of rats (%) Total number of tumors Mean tumor No./rat (mean±SE) p
I1 6 7 5 5 3 3 . 3 ±0.75
p=0.009 II 16 69 33 2.1±0.51
III 16 38 17 1.0±0.42Milk and Rat Mammary Tumors 63
milk and estrone sulfate groups. At autopsy, the cumulative
number of tumors in the milk, estrone sulfate, and water
groups was 53, 33, and 17, respectively. Mean number of
tumors per rat in the milk, estrone sulfate, and water groups
was 3.3, 2.1, and 1.0, respectively. Mean tumor number per
rat in milk group was significantly higher than that in the
water group.
Histology of mammary tumors
Several histological types were recognized in mam-
mary tumors induced by DMBA. According to histological
findings, tumors were classified into 3 histological types:
intraductal papilloma, fibroadenoma, and adenocarcinoma.
Intraductal papilloma is the most common type of tumor
in this experiment. Figure 1A shows a typical intraductal
papilloma. The papillae containing both epithelial cells and
myoepithelial cells are composed of a core of fibrovascu-
lar tissue lined by a single layer of cuboidal or low cylindri-
cal epithelial cells. The epithelial cells are homogeneous in
size and shape; they have leptochromatic nuclei, and the
nucleolus is either absent or inconspicuous; some cellular
atypia  and  mitoses may be present but scarce. Fibroade-
noma is a benign tumor composed of mammary epithelium
and numerous connective tissues. Ductal and lobular struc-
tures are surrounded with layers of fibrous tissue. As with
normal rat mammary gland, the epithelium underlies the
myoepithelium and basement membrane (Fig. 1B). Adeno-
carcinoma is characterized by the loss of the tubular-alveolar
pattern. Solid sheets of neoplastic epithelial cells are inter-
rupted by secondary lumina of round, oval or irregular
shape and variable size, representing a cribriform pattern. No
single metastasis was noted, while vascular local invasion
can be seen sporadically in many tumors. Individual neo-
plastic cells are moderately to markedly pleomorphic, the
degree of pleomorphism varies from tumor to tumor and
even in different areas of the same tumor (Fig. 1C). As in
human mammary carcinoma, the different types were not
clearly defined and were found in different parts of the
same tumor.
The results of histological classification are summa-
rized in Table 2. Most of the tumors were diagnosed as intra-
ductal papilloma or fibroadenoma. There was no significant
difference in the percentages of histological types among the
three groups. However, the milk group and estrone sulfate
group developed adenocarcinoma but the water group did
not.
Immunohistochemistry of SMA, ERα, and PCNA
Immunoperoxidase reaction with anti-alpha SMA anti-
body revealed elongated myoepithelial-like cells at the
periphery of epithelial cell nests and glandular structures in
all tumors. Appearance and number of myoepithelial cells
showing positive for SMA varied among different histo-
logical types of rat breast tumors. Most of the epithelial
cell  nests  in intraductal papilloma are lined by myoepi-
thelial cells (Fig. 2A). Adenocarcinoma were also positive
for SMA immunostaining and myoepithelial cells were
stretched and scattered at the base of the epithelial cell nests.
Additionally, the number of myoepithelial cells in adeno-
carcinoma was apparently lower than that in intraductal
Fig. 1. HE staining of rat mammary tumor. A) Intraductal papilloma.
Numerous papillary projections sustained by thin connective tissue
cores can be seen. HE×25.  B) Fibroadenoma. Fibrous stroma is
compressing the tubular alveolar components. HE×25. C) Adeno-
carcinoma. Numerous secondary lumina can be seen. HE×25.Ma et al. 64
papilloma (Fig. 2C). Fibroadenoma showed immunohisto-
chemistry patterns which were intermediate between intra-
ductal papilloma and adenocarcinoma (Fig. 2B).
ERα positive cells were indicated by intensely stained
nuclei and observed in all tumors (Fig. 3A–C). There were
no significant differences in the appearance and the number
of ERα positive cells among the three histological types of
rat breast tumors.
PCNA immunostaining was confined to nuclei of
tumor cells, suggesting proliferating cells (Fig. 4A–C). We
quantified the PCNA-labeled cells in 30 intraductal papil-
lomas, 10 fibroadenomas, and 4 adenocarcinomas using
ACT-1 Image Analysis System (Nikon, Japan). The results
of PCNA labeling index are shown in Table 3. PCNA label-
ing index was 24±8% in intraductal papilloma, 36±8% in
fibroadenoma, and 56±10% in adenocarcinoma. It was sig-
nificantly different in the PCNA labeling index among the
three histological types of rat breast tumors (p<0.001).
IV.  Discussion
Considerable epidemiological studies have shown a
positive association between milk and breast cancer [24, 27].
Ganmaa and Sato correlated incidence rates for breast,
ovarian, and corpus uteri cancers with food intake in 40
countries [5], and put forth the hypothesis that milk and
dairy products have a significant effect on the development
of these cancers. However, there were few animal experi-
ments to verify this hypothesis. The present study clearly
demonstrated that the tumor incidence in the milk group
was significantly higher than that in the water group and
comparable to that in the estrone sulfate group. The milk
group developed more than one third as many tumors as the
water group. These results, therefore, suggest that milk as
well as estrone sulfate has a stimulatory effect on the
development of DMBA-induced rat mammary tumors.
Fig. 2. Immunostaining  for  SMA.  A) Immunoperoxidase reaction
with anti-alpha smooth muscle actin antibody reveals myoepithelial
cells lining nests of secretory cells in intraductal papilloma. Nuclei
counterstained with HE×100. B) Immunoperoxidase reaction with
anti-alpha smooth muscle actin antibody reveals that myoepithelial
cells scattered at the base of nests in fibroadenoma. Nuclei counter-
stained with HE×100.  C) Immunoperoxidase reaction with anti-
alpha smooth muscle actin antibody reveals that myoepithelial cells
scattered at the base of nests and stretched in adenocarcinoma.
Nuclei counterstained with HE×100.
Table 2. Histological type of tumors
I, milk group; II, estrone sulfate group; III, water group; IDP, intraductal papilloma; FA, fibroadenoma; AC, adenocarcinoma.
Group Total number of tumors
Histological type
IDP (%) FA (%) AC (%)
I 53 44 (83%) 7 (13%) 2 (4%)
II 33 24 (73%) 7 (21%) 2 (6%)
III 17 14 (82%) 3 (18%) 0 (0%)Milk and Rat Mammary Tumors 65
Although the mechanisms by which milk could alter
tumorigenesis are unknown, there are some hypotheses that
have been put forth to suggest an increased risk of breast
cancer associated with consumption of milk. Studies of
dietary sources of nutrients estimate that the proportion of
saturated fat in the diet that comes from dairy products is
about 31% in the United States and 50% in Sweden [25, 30].
Fig. 3. Immunostaining for ER. Nuclear staining indicates immuno-
reactive ER. Nuclei counterstained with HE. A) Intraductal papil-
loma, B) Fibroadenoma, C) Adenocarcinoma. ×100.
Fig. 4. Immunostaining for PCNA. Nuclear staining indicates
immunoreactive PCNA. Nuclei counterstained with haematoxylin.
A) Intraductal papilloma. PCNA labeling index is low. B) Fibro-
adenoma. PCNA labeling index is moderate. C) Adenocarcinoma.
PCNA labeling index is high. ×100.Ma et al. 66
Some animal studies for breast cancer proved that high fat
diets increase the incidence of spontaneous, chemically
induced, and radiation-induced mammary tumors [1, 7].
Therefore, a high consumption of milk may results in a high
dietary fat intake, particularly saturated fat, which in turn
increases breast cancer risk.
Another hypothesis suggesting an increased risk of
breast cancer with high milk intake focuses on the insulin-
like growth factor I (IGF-I). Some investigators found that
bovine growth hormone, which is sometimes administered
to dairy cattle to increase milk production, resulted in in-
creased concentrations of IGF-I in milk [16]. IGF-I concen-
trations in commercial milk have been reported to range
from 6 to 162 ng/ml [13]. In a human study, plasma IGF-I
concentration increased by 10% when healthy subjects con-
sumed commercial milk [8]. IGF-I has been shown to pro-
mote breast cancer cell growth and some experiments found
that removing or blocking IGF-I receptors from the cell
membrane can abolish viral or cellular oncogene-induced
malignant transformation [31]. Therefore, IGF-I in milk may
promote the development of tumors induced by DMBA in
rat.
Estrogens are breast cancer promoters because of their
physiological role in stimulating the mammary gland [28].
Our present experiment also demonstrated that estrone
sulfate can stimulate the development of tumors induced
by DMBA in rat. Moreover, all tumors induced by DMBA
in the present experiment were positive for ERα. Russo et
al. reported that mammary tumors in the rat are generally
strongly hormone-dependent for both induction and growth
[19]. Qin et al. measured the estrogen concentration of com-
mercial milk and recently reported that the estrogen concen-
tration in commercial milk was about 703.3 pg/ml [17].
Although the concentration of estrogen in milk is not very
high, Ganmaa et al. have proved that commercial milk has a
biologically significant hormonal effect and reported that the
uterotrophic effect of commercial milk was almost compara-
ble to that of 100 ng/ml estrone sulfate solution [6]. In this
respect, estrogen in milk can be responsible for tumor pro-
motion.
In our present experiment, we classified the mammary
tumors induced by DMBA into three histological types:
intraductal papilloma, fibroadenoma, and adenocarcinoma.
The rates of benign tumors (intraductal papilloma and fibro-
adenoma) were almost the same among the three groups.
However, malignant tumor (adenocarcinoma) was found
only in milk and estrone sulfate groups. Van Zwieten has
reported that the administration of estrogen results in an in-
crease in the proportion of rats with malignant tumors, espe-
cially cribriform carcinomas [29]. Results of our present ex-
periment suggested that milk as well as estrone sulfate could
be associated with the occurrence of adenocarcinoma.
According to histological appearance, we classified
four tumors as malignant. However, SMA immunostaining
of these four adenocarcinomas also presented positive.
Papotti et al. studied the cellular composition of rat mam-
mary carcinoma by both light and electron microscopy [15].
They found that mammary myoepithelial cells were a con-
stant component in mammary carcinoma. Evidence of the
presence of myoepithelial cells in DMBA-induced rat
mammary carcinoma has also been reported in some other
studies [11]. Therefore, although the presence of myoepithe-
lial cells is commonly regarded as a hallmark of benignity
in humans, myoepithelial cells will present as a constant in
rat mammary carcinomas. PCNA is an essential replication
factor to initiate cell cycle progression [12]. The number
of PCNA-labeled cells generally is higher in malignant
tumors than in benign ones. In our present experiment,
PCNA labeling index of adenocarcinoma was significantly
higher than that of intraductal papilloma and fibroadenoma.
Thus, PCNA immunostaining is useful for histological classi-
fication of rat mammary tumors.
In conclusion, milk as well as estrone sulfate promoted
the development of DMBA-induced mammary tumors in
rat and could be associated with the occurrence of adeno-
carcinoma. Immunohistochemical staining for SMA and
PCNA was a useful auxiliary for histological classification
of tumors.
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